Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

An Eco-Friendly Technique: Solvent-Free Microwave Synthesis and Docking Studies of Some New Pyridine Nucleosides and Their Pharmacological Significance.

Alrobaian M, Azwari SA, Belal A, Eldeab HA.

Molecules. 2019 May 22;24(10). pii: E1969. doi: 10.3390/molecules24101969.

2.

Design, synthesis, molecular docking and biological activity evaluation of some novel indole derivatives as potent anticancer active agents and apoptosis inducers.

El-Sharief AMS, Ammar YA, Belal A, El-Sharief MAMS, Mohamed YA, Mehany ABM, Elhag Ali GAM, Ragab A.

Bioorg Chem. 2019 Apr;85:399-412. doi: 10.1016/j.bioorg.2019.01.016. Epub 2019 Jan 8.

PMID:
30665034
3.

Hybridized quinoline derivatives as anticancer agents: Design, Synthesis, biological evaluation and molecular docking.

Selim MR, Zahran MA, Belal A, Mostafa MS, Shedid SA, Mehany ABM, Elhagali GAM, Ammar YA.

Anticancer Agents Med Chem. 2018 Nov 12. doi: 10.2174/1871520618666181112121058. [Epub ahead of print]

PMID:
30417798
4.

Design, synthesis, antiproliferative activity, molecular docking and cell cycle analysis of some novel (morpholinosulfonyl) isatins with potential EGFR inhibitory activity.

Ammar YA, Sh El-Sharief AM, Belal A, Abbas SY, Mohamed YA, Mehany ABM, Ragab A.

Eur J Med Chem. 2018 Aug 5;156:918-932. doi: 10.1016/j.ejmech.2018.06.061. Epub 2018 Jun 28.

PMID:
30096580
5.

Pyrrolizines as Potential Anticancer Agents: Design, Synthesis, Caspase-3 activation and Micronucleus (MN) Induction.

Belal A.

Anticancer Agents Med Chem. 2018;18(15):2124-2130. doi: 10.2174/1871520618666180409155520.

PMID:
29629667
6.

Design, synthesis, biological evaluations, molecular docking, and in vivo studies of novel phthalimide analogs.

Zahran MAH, El-Aarag B, Mehany ABM, Belal A, Younes AS.

Arch Pharm (Weinheim). 2018 May;351(5):e1700363. doi: 10.1002/ardp.201700363. Epub 2018 Apr 3.

PMID:
29611624
7.

DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW PYRROLOAZEPINES WITH POTENTIAL AND SELECTIVE ANTITUMOR ACTIVITY.

Jaiash DA, Belal A, Abdelgawad MA, Abdellatif KR.

Acta Pol Pharm. 2016 Mar-Apr;73(2):359-68.

PMID:
27180428
8.
9.

Design, synthesis, and molecular docking studies of 2-(furan-2-yl)quinazolin-4-one derivatives as potential antiproliferative agents.

Ahmed MF, Belal A.

Arch Pharm (Weinheim). 2015 Jul;348(7):487-97. doi: 10.1002/ardp.201400468. Epub 2015 Apr 29.

PMID:
25921702
10.

Synthesis, molecular docking and antitumor activity of novel pyrrolizines with potential as EGFR-TK inhibitors.

Belal A.

Bioorg Chem. 2015 Apr;59:124-9. doi: 10.1016/j.bioorg.2015.02.006. Epub 2015 Feb 21.

PMID:
25748126
11.

Design, synthesis and anticancer activity evaluation of some novel pyrrolo[1,2-a]azepine derivatives.

Belal A.

Arch Pharm (Weinheim). 2014 Jul;347(7):515-22. doi: 10.1002/ardp.201400004. Epub 2014 Apr 14.

PMID:
24729464
12.

Pyrrolizines: Promising scaffolds for anticancer drugs.

Belal A, El-Gendy Bel-D.

Bioorg Med Chem. 2014 Jan 1;22(1):46-53. doi: 10.1016/j.bmc.2013.11.040. Epub 2013 Dec 1. Review.

PMID:
24331756
13.

Design, synthesis and biological evaluation of novel triaryl (Z)-olefins as tamoxifen analogues.

Abdellatif KR, Belal A, Omar HA.

Bioorg Med Chem Lett. 2013 Sep 1;23(17):4960-3. doi: 10.1016/j.bmcl.2013.06.056. Epub 2013 Jun 26.

PMID:
23860592
14.

Synthesis, anti-breast cancer activity, and molecular modeling of some benzothiazole and benzoxazole derivatives.

Abdelgawad MA, Belal A, Omar HA, Hegazy L, Rateb ME.

Arch Pharm (Weinheim). 2013 Jul;346(7):534-41. doi: 10.1002/ardp.201300044. Epub 2013 Jun 5.

PMID:
23740859

Supplemental Content

Loading ...
Support Center